These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 34268874)

  • 1. Establishment of a nomogram with EMP3 for predicting clinical outcomes in patients with glioma: A bi-center study.
    Zhang A; Xu H; Zhang Z; Liu Y; Han X; Yuan L; Ni Y; Gao S; Xu Y; Chen S; Jiang J; Chen Y; Zhang X; Lou M; Zhang J
    CNS Neurosci Ther; 2021 Oct; 27(10):1238-1250. PubMed ID: 34268874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico identification of the prognostic biomarkers and therapeutic targets associated with cancer stem cell characteristics of glioma.
    Lvu W; Fei X; Chen C; Zhang B
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32725165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ferroptosis-related gene signature correlates with the tumor immune features and predicts the prognosis of glioma patients.
    Hu Y; Tu Z; Lei K; Huang K; Zhu X
    Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34726238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An autophagic gene-based signature to predict the survival of patients with low-grade gliomas.
    Chen J; Li Y; Han X; Pan Y; Qian X
    Cancer Med; 2021 Mar; 10(5):1848-1859. PubMed ID: 33591634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas.
    Zhang H; Li X; Li Y; Chen B; Zong Z; Shen L
    Front Immunol; 2020; 11():603341. PubMed ID: 33363544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial Membrane Protein-3 and Chitinase-3-like Protein-1 as New Prognostic Predictors of Glioma, a Two-Gene Study.
    Shen K; Zhu J; Zhou S; Jin X; Zhai W; Sun L; Wu J; Yu Z
    Curr Oncol; 2023 Sep; 30(10):8686-8702. PubMed ID: 37887529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N6-methyladenine-related genes affect biological behavior and the prognosis of glioma.
    Qu S; Chen Z; Liu B; Liu J; Wang H
    Cancer Med; 2021 Jan; 10(1):98-108. PubMed ID: 33264518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Multifunctional Role of EMP3 in the Regulation of Membrane Receptors Associated with IDH-Wild-Type Glioblastoma.
    Martija AA; Pusch S
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34067658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a nomogram for prognostic prediction of lower-grade glioma based on alternative splicing signatures.
    Wang Y; Wang Z; Zhao B; Chen W; Wang Y; Ma W
    Cancer Med; 2020 Dec; 9(24):9266-9281. PubMed ID: 33047900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EMP3 as a prognostic biomarker correlates with EMT in GBM.
    Li L; Xia S; Zhao Z; Deng L; Wang H; Yang D; Hu Y; Ji J; Huang D; Xin T
    BMC Cancer; 2024 Jan; 24(1):89. PubMed ID: 38229014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ARL3 is downregulated and acts as a prognostic biomarker in glioma.
    Wang Y; Zhao W; Liu X; Guan G; Zhuang M
    J Transl Med; 2019 Jun; 17(1):210. PubMed ID: 31234870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Autophagy Signature-Based Prognostic Nomogram for Refined Glioma Survival Prognostication.
    Fan Y; Peng X; Li B; Zhao G
    Biomed Res Int; 2020; 2020():1872962. PubMed ID: 32964017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and validation of a five-lncRNA prognostic signature related to Glioma using bioinformatics analysis.
    Zhang C; Liu H; Xu P; Tan Y; Xu Y; Wang L; Liu B; Chen Q; Tian D
    BMC Cancer; 2021 Mar; 21(1):251. PubMed ID: 33750353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoter hypermethylation of the EMP3 gene in a series of 229 human gliomas.
    Mellai M; Piazzi A; Caldera V; Annovazzi L; Monzeglio O; Senetta R; Cassoni P; Schiffer D
    Biomed Res Int; 2013; 2013():756302. PubMed ID: 24083241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of an Immune-Related Gene Signature for Risk Stratification for Patients with Glioma.
    He J; Zeng C; Long Y
    Comput Math Methods Med; 2021; 2021():2191709. PubMed ID: 34497663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evaluation of six genes combined value in glioma diagnosis and prognosis.
    Lin P; He L; Tian N; Qi X
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):12413-12433. PubMed ID: 37439825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive exploration of tumor mutational burden and immune infiltration in diffuse glioma.
    Kang K; Xie F; Wu Y; Wang Z; Wang L; Long J; Lian X; Zhang F
    Int Immunopharmacol; 2021 Jul; 96():107610. PubMed ID: 33848908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors and clinical nomogram predicting survival in high-grade glioma.
    Tunthanathip T; Ratanalert S; Sae-Heng S; Oearsakul T; Sakarunchai I; Kaewborisutsakul A; Chotsampancharoen T; Intusoma U; Kitkhuandee A; Vaniyapong T
    J Cancer Res Ther; 2021; 17(4):1052-1058. PubMed ID: 34528563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An independently validated survival nomogram for lower-grade glioma.
    Gittleman H; Sloan AE; Barnholtz-Sloan JS
    Neuro Oncol; 2020 May; 22(5):665-674. PubMed ID: 31621885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma.
    Maimaiti A; Wang X; Pei Y; Nuermaimaiti N; Tuersunniyazi A; Abula Y; Feng Z; Jiang L; Shi X; Kasimu M
    Aging (Albany NY); 2021 Jun; 13(11):15164-15192. PubMed ID: 34081618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.